Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Eli Lilly Just Added Another Potential Billion-Dollar Product: Is It a Buy?

TheMotleyFool

0 0

Eli Lilly Just Added Another Potential Billion-Dollar Product: Is It a Buy?: https://g.foolcdn.com/editorial/images/753102/doctor-with-patient-talking.jpg

Investors looking for a stock that has crushed the market this year need look no further than pharmaceutical giant Eli Lilly (NYSE: LLY). The drugmaker has been on a tear on the back of excellent financial results and solid clinical progress. However, Eli Lilly has, so far, failed to accomplish some of the goals it set out for itself for 2023. Some of the treatments it aimed to launch have encountered regulatory obstacles.

Thankfully, these issues haven't slowed Eli Lilly, and the company is working to resolve them. Case in point: It recently earned approval for a medicine that was initially rejected by the Food and Drug Administration (FDA).